Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency
NCT ID: NCT04498455
Last Updated: 2020-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
11 participants
INTERVENTIONAL
2018-09-30
2019-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy on Overweight With Oral Supplemenation of Probiotics and Prebiotics
NCT05710055
Probiotics and Insulin Resistance in Obese Asthmatics
NCT05949255
Probiotics in Obesity Management
NCT06964932
Use of Probiotics to Aid in Weight Loss
NCT01445704
Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Obesity
NCT02733484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Dietary Supplement: Placebo
Prebiotin
Fructo-oligosaccharide dietary supplement powder
Prebiotin
Dietary Supplement: Prebiotin (oligofructose enriched inulin)
Prebiotin
Fructo-oligosaccharide dietary supplement powder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prebiotin
Fructo-oligosaccharide dietary supplement powder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Currently on prescribed metformin or NSAIDS
* A diagnosed gastro-intestinal disease (i.e. irritable bowel syndrome or Crohn's disease)
* Known allergy to the supplement, placebo, or provided meal replacements
* Antibiotic use within the last 3 months.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baylor University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leigh Greathouse
Assistant Professor of Nutrition Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
LesLee Funderburk, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Baylor University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baylor University
Waco, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Study analysis
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1255329-5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.